Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives
- 14 October 2010
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 32 (12) , 1712-1719
Abstract
Background. To date, more than 60 gene expression profiling (GEP) studies have been published in the field of head and neck squamous cell carcinoma (HNSCC) with variable objectives, methods, and results. Methods. The purpose of this study was to present a state‐of‐the‐art review of GEP in HNSCC focusing on the current advances and perspectives for clinical applications. Results. Gene expression signatures have been developed to identify screening and diagnostic molecular markers, to improve tumor staging (cervical lymph node and distant metastasis prediction), to differentiate lung metastasis of HNSCC from primary lung squamous cell carcinoma, to predict tumor response to chemoradiotherapy, and to provide outcome predictors. Conclusion. Some transcriptional signatures that could improve HNSCC management have been identified, but further analyses are required to properly validate and to precisely evaluate their clinical relevance. After an exploratory phase, the completion of large scale projects with stringent methodology is now necessary to transfer GEP from bench to bedside. © 2010 Wiley Periodicals, Inc. Head Neck, 2010Keywords
This publication has 45 references indexed in Scilit:
- Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene SignatureClinical Cancer Research, 2010
- Genes involved in radiation therapy response in head and neck cancersThe Laryngoscope, 2008
- Next-generation sequencing: applications beyond genomesBiochemical Society Transactions, 2008
- The Evolving Transcriptome of Head and Neck Squamous Cell Carcinoma: A Systematic ReviewPLOS ONE, 2008
- A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell CarcinomaClinical Cancer Research, 2007
- Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell CarcinomaCancer Research, 2006
- Expression profiling and prediction of distant metastases in head and neck squamous cell carcinomaJournal of Clinical Pathology, 2006
- Prediction of response to imatinib by cDNA microarray analysisSeminars in Hematology, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- How to improve the present TNM staging systemCancer, 1999